Cleared Traditional

Blood Pressure Monitor (K200437) - FDA 510(k) Clearance

Class II Cardiovascular device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2020
Decision
122d
Days
Class 2
Risk

K200437 is an FDA 510(k) clearance for the Blood Pressure Monitor. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Shenzhen Jamr Technology Co., Ltd. (Shenzhen, CN). The FDA issued a Cleared decision on June 25, 2020 after a review of 122 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Shenzhen Jamr Technology Co., Ltd. devices

Submission Details

510(k) Number K200437 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 24, 2020
Decision Date June 25, 2020
Days to Decision 122 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
3d faster than avg
Panel avg: 125d · This submission: 122d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 269
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K200437.
AGE Automatic Wrist Blood Pressure Monitor
K193628 · Dongguan E-Test Technology Co., Ltd. · Jul 2020
Automatic Upper Arm Blood Pressure Monitor
K193624 · Dongguan E-Test Technology Co., Ltd. · Jul 2020
Blood Pressure Monitor
K193348 · Shenzhen Viatom Technology Co., Ltd. · Jun 2020
Microlife Upper Arm Automatic Digital Blood Pressure Monitor
K200297 · Microlife Intellectual Property GmbH · Jun 2020
Full Automatic(NIBP) Blood Pressure Monitor
K200521 · Health & Life Co., Ltd. · Jun 2020
Automatic Digital Blood Pressure Monitor
K190982 · Xiamen Ants Bro Technology Co., Ltd. · May 2020